Retrospective Study of Reoperation After Primary Augmentation With NATRELLE® INSPIRA® Breast Implants (RANBI-I)

July 22, 2016 updated by: Allergan
This study will evaluate the incidence of reoperations associated with the use of smooth and textured NATRELLE® INSPIRA® TruForm® 1 and TruForm® 2 devices in patients who have undergone primary breast augmentation.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
330

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
      • Quebec, Canada, G1V 1R4
        • Clinique de Chirurgie Plastique et Esthétique de la Haute-Ville
      • Quebec, Canada, G1V 4M6
        • Sebastien Nguyen MD Inc.
    • Alberta
      • Banff, Alberta, Canada, T1L 1B7
        • Banff Plastic Surgery
      • Calgary, Alberta, Canada, T2H 0L8
        • Macleod Trail Plastic Surgery
      • Edmonton, Alberta, Canada, T5M 327
        • Jonathan Toy
    • British Columbia
      • Langley, British Columbia, Canada, V2Y 0C8
        • Y.E.S MedSpa & Cosmetic Surgery Centre
    • Ontario
      • Oakville, Ontario, Canada, L6J 7W5
        • Institute of Cosmetic and Laser Surgery
      • Ottawa, Ontario, Canada, K1Z 8R9
        • Ottawa Plastic Surgery: Dr. Howard Silverman
      • Toronto, Ontario, Canada, M2J 1V1
        • Rice Cosmetic Surgery
      • Toronto, Ontario, Canada, M2P 2C2
        • Cosmedical Rejuvenation Clinic
      • Toronto, Ontario, Canada, M5R 2J3
        • Yorkville Institute of Plastic Surgery
      • Waterloo, Ontario, Canada, N2J 1M3
        • SpaSurgica
    • Quebec
      • Boucherville, Quebec, Canada, J4B 7M6
        • Centre de Medecine et de Chirurgie Ambulatoires Isomed
      • Montreal, Quebec, Canada, H3G 1B9
        • CCPEM
      • Pointe-Claire, Quebec, Canada, H9R 5N3
        • Cosmedica
      • Waterloo, Quebec, Canada, N2L 3S2
        • Cosmetic Surgery Clinic
      • Westmount, Quebec, Canada, H3Z 1S3
        • Sandra McGill MD Inc.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Subjects that have undergone a primary breast augmentation for aesthetic reasons with NATRELLE® INSPIRA® TruForm® 1 or TruForm® 2 implant.

Description

Inclusion Criteria:

  • Primary breast augmentation (either bilateral or unilateral) operated on by the investigating surgeon with an infra-mammary approach smooth or textured NATRELLE® INSPIRA® TruForm® 1 or 2 device
  • Primary breast augmentation 2 to 4 years (24-48 months) prior to data collection
  • Subfascial, submuscular, dual plane or subglandular implant placement

Exclusion Criteria:

  • Breast augmentation for Poland Syndrome or amastia
  • Breast reconstruction following mastectomy
  • Revision or secondary breast reconstruction
  • Non NATRELLE® INSPIRA® device implanted at initial breast augmentation
  • Women diagnosed with breast disease considered to be pre-malignant or malignant prior to or at the time of primary breast augmentation
  • Surgical procedures of the breast not related to the primary breast augmentation (e.g. excision of significant skin lesions or a biopsy) occurring prior to or at the time of primary augmentation that may adversely affect the aesthetic outcome in the opinion of the investigator
  • Axillary or peri-areolar approach
  • Mastopexy augmentation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
NATRELLE® INSPIRA® TruForm® 1 (Smooth)
Subjects receiving primary breast augmentation with smooth NATRELLE® INSPIRA® TruForm® 1 breast implants
Device: Smooth NATRELLE® INSPIRA® TruForrm® 1 Breast Implants
Surgical implant
Other Names:
  • Round cohesive, gel-filled breast implants (low, low plus, moderate, full, or extra full projection)
NATRELLE® INSPIRA® TruForm® 1 (Textured)
Subjects receiving primary breast augmentation with textured NATRELLE® INSPIRA® TruForm® 1 breast implants
Device: Textured NATRELLE® INSPIRA® TruForm® 1 Breast Implants
surgical implant
Other Names:
  • Round cohesive, gel-filled breast implants (low, low plus, moderate, full, or extra full projection)
NATRELLE® INSPIRA® TruForm® 2 (Smooth)
Subjects receiving primary breast augmentation with smooth NATRELLE® INSPIRA® TruForm® 2 breast implants
Device: Smooth NATRELLE® INSPIRA® TruForrm® 2 Breast Implants
surgical implant
Other Names:
  • Round cohesive, gel-filled breast implants (low, low plus, moderate, full, or extra full projection)
NATRELLE® INSPIRA® TruForm® 2 (Textured)
Subjects receiving primary breast augmentation with textured NATRELLE® INSPIRA® TruForm® 2 breast implants
Device: Textured NATRELLE® INSPIRA® TruForm® 1 Breast Implants
surgical implant
Other Names:
  • Round cohesive, gel-filled breast implants (low, low plus, moderate, full, or extra full projection)

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Time Frame
Incidence of Reoperations of All Cause Following the Use of Smooth or Textured NATRELLE® INSPIRA® TruForm® 1 or TruForm® 2 Breast Implants
Time Frame: 4 Years
4 Years

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Time Frame
Incidence (by Product Type) of First Reoperation Following the Use of Smooth or Textured NATRELLE® INSPIRA® TruForm®1 or TruForm® 2 Breast Implants
Time Frame: 4 Years
4 Years
Reasons For Primary Augmentation
Time Frame: 4 Years
4 Years
Time From the Date of Implant Until First Reoperation
Time Frame: 4 Years
4 Years
Reasons For Reoperation Incidence
Time Frame: 4 Years
4 Years
Incidences of Implant Removal With Replacement
Time Frame: 4 Years
4 Years
Incidences of Implant Removal Without Replacement
Time Frame: 4 Years
4 Years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Allergan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
December 1, 2014

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 1, 2016

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 1, 2016

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 6, 2015

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 7, 2015

First Posted (Estimate)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 8, 2015

Study Record Updates

Last Update Posted (Estimate)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 25, 2016

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 22, 2016

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • GMA-CAN-PLS-0337

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Implantation

Clinical Trials on Smooth NATRELLE® INSPIRA® TruForrm® 1 Breast Implants

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings